Particle.news

Download on the App Store

MIT Launches Human Trials for 40Hz Sensory Therapy After Breakthrough in Down Syndrome Mice

The GENUS protocol, shown to improve memory, neurogenesis, and synaptic connectivity in mice, is now being tested for its potential benefits in people with Down syndrome.

Image
Image

Overview

  • The GENUS method uses 40Hz light and sound stimulation to synchronize brain activity and restore cognitive function.
  • Preclinical trials in Ts65Dn mice demonstrated improved short-term memory, increased neurogenesis, and higher synaptic density in the hippocampus.
  • The study also linked GENUS stimulation to partial restoration of TCF4 expression and preservation of Reelin-expressing neurons, key for synaptic plasticity and cognitive resilience.
  • This is the first research to directly connect gamma frequency stimulation with enhanced neurogenesis in a neurodevelopmental disorder model.
  • MIT researchers have initiated early-phase human trials to evaluate the safety and efficacy of GENUS in people with Down syndrome, marking a significant step toward clinical application.